Hindi and world cinema lost a shining star when Irrfan Khan passed away yesterday, April 29, 2020. The actor, who was battling Neuroendocrine cancer for two years, left his fans and the industry in shock and sorrow after he passed away.
Irrfan Khan was admitted to Kokilaben Dhirubhai Ambani Hospital in Andheri, Mumbai, for a colon infection, where he breathed his last. Irrfan was laid to rest at 3 pm yesterday.
In a recent interview with ETimes, actress Mrinal Kulkarni opened up about Irrfan Khan, who was her TV show Shrikant co-star. Kulkarni shared, "The thing is, I am working with cancer organisations for the last few years and then I got to know about Irrfan. We were connected to each other when he was a cancer survivor but his cancer was of a rare type and even after being a strong-willed person he couldn't win the battle. Sometimes, there is nothing in our hands and that is true."
Mrinal Kulkarni, who worked with Irrfan Khan in another TV show, Sparsh, added, "Actually, I knew he was not well and it was a tough fight. After losing his mother, he became more weak and emotional. I somewhere felt that there were tough times ahead for him." Irrfan Khan's mother, Saeda Begum, passed away on April 25, 2020, at age 95.
Talking about Irrfan Khan as an actor and individual, Kulkarni shared, "He used to speak very less. I didn't know that we would ever become friends. After that, we worked together a lot and we became best friends."
Irrfan Khan's last film, Angrezi Medium, released in March this year. He was known for his performances in films like Maqbool, The Namesake, A Mighty Heart, Paan Singh Tomar, Life of Pi, The Lunchbox, and Hindi Medium, among others.
Catch up on all the latest entertainment news and gossip here. Also, download the new mid-day Android and iOS apps.
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news
from Latest news in Mumbai,National news,Mumbai news,Mid-Day epaper,Mid-Day online news paper | Mid-Day https://ift.tt/2zGtXRb
https://ift.tt/eA8V8J https://ift.tt/1L8zhvV
0 Comments